Table 2

Residual disease activity in different measures for remission

PASDASMean (SD)cDAPSA remission (total 113)DAPSA remission (total 107)VLDA (total 56)PASDAS <1.9
(n=37)
2.16 (0.52)2.13 (0.49)1.97 (0.42)1.6 (0.20)
Swollen joint count
n (%)
0101 (89)96 (90)53 (95)33 (89)
1–312 (11)11 (10)3 (5)4 (11)
4–60 (−)0 (−)0 (−)0 (−)
Tender joint count
n (%)
093 (82)89 (83)51 (91)28 (76)
1–320 (18)18 (17)5 (9)6 (16)
4–70 (−)0 (−)0 (−)2 (8)
8+0 (−)0 (−)0 (−)0 (−)
Leeds enthesitis index
n (%)
0108 (96)102 (96)56 (100)37 (100)
1–24 (−)4 (−)0 (−)0 (−)
41 (−)1 (−)0 (−)0 (−)
Dactylitis count n (%)0113 (100)107 (100)56 (100)37 (100)
PASI n (%)0–179 (70)74 (69)56 (100)32 (86)
>134 (30)33 (31)0 (−)5 (14)
CRP >normal value (5 mg/L) n (%)11 (10)8 (7.5)5 (9)1 (3)
  • cDAPSA, clinical DAPSA; CRP, C reactive protein; DAPSA, Disease Activity Index for Psoriatic Arthritis; PASDAS, Psoriatic Arthritis Disease Activity Score; PASI, psoriasis area and severity index; VLDA, very low disease activity.